Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 54.00
-2.60 (-4.59%)
Mar 4, 2026, 11:10 AM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 27.08 billion as of March 3, 2026. Its market cap has decreased by -26.06% in one year.
Market Cap
27.08B
Enterprise Value
22.06B
Revenue
117.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.00
Market Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 27.08B, an increase of 2,084.21%. That is a compound annual growth rate of 20.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 27.08B | 1.80% |
| Dec 31, 2025 | 26.60B | -36.18% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 44.56B |
| Lin BioScience | 33.79B |
| Lumosa Therapeutics | 29.14B |
| Polaris Group | 25.66B |
| Sunmax Biotechnology | 21.57B |
| EirGenix | 18.52B |
| AP Biosciences | 15.15B |
| TaiMed Biologics | 14.04B |